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Abstract  
In this work we demonstrate that Caco-2 cell treatment with WY-14643 (a potent 
PPAR agonist) causes an increase in AhR expression. Luciferase assays and 
directed mutagenesis experiments showed that induction mainly occurred at 
transcriptional level and involved a PPRE site located within the AhR promoter. 
These results were further confirmed by the use of PPAR knockout mice in which 
AhR induction by WY14643 was abrogated. In addition to CYP1 regulation, AhR has 
been described as being involved in inflammation, so we also studied the effect of 
AhR regulation by PPAR on the expression of some inflammation target genes. 
3-Methylcholanthrene (a potent AhR agonist) increased the expression (mRNA) of 
the major inflammatory targets IL-1 and MMP9. WY-14643 co-treatment abrogated 
the 3-methylcholanthrene proinflammatory effect. Hence the anti-inflammatory effect 
of PPAR overrides the pro-inflammatory effect of AhR. 
 
Introduction 
Our daily diet exposes us to an array of compounds that include nutrients such as 
fatty acids and cooking by-products such as polycyclic aromatic hydrocarbons 
(PAHs), which can modulate the expression of various target proteins, including 
transcription factors. The gut can thus be considered as a primary target organ, yet 
the effects of such coexposure on its biological functions are little known. 
Ah receptor (AhR) can be activated by food products such as PAHs formed during fat 
pyrolysis, and indoles found in cruciferous vegetables. The role of AhR in the 
regulation of CYP1 expression and some phase 2 enzymes of xenobiotic metabolism 
has been extensively studied, owing to the role of CYP1 in carcinogenesis [1]. CYP1 
catalyses the bioactivation of numerous procancerogens including PAHs and 
arylamines, which are thought to be involved in the aetiology of colon cancers. 
Recent data have suggested that AhR is also involved in the inflammation process. 
The transcription factor NFB is a central mediator of the immune and inflammatory 
response [2]. It is regulated through the binding of inhibitory molecules referred to as 
the IB proteins. On activation, NFB rapidly enhances the expression of 
proinflammatory genes such as cytokines and cell adhesion molecules. A molecular 
interaction has been described between AhR and the NFB RelA sub-unit, forming a 
heterodimer able to activate the NFB responsive elements [3]. Using mice with triple 
knockout of receptors for TNF, TNF and IL-1 and IL-1, it was found that the 
hepatic inflammation induced by dioxins was mediated by "IL-1-like" cytokines [4]. 
Also, PPAR, in addition to its role as an important lipid sensor and regulator of 
cellular energy-harvesting metabolism, has been reported to be involved in the 
physiopathology of the inflammatory process, notably by repressing NFB and 
activator protein-1 (AP-1) signaling [5]. 
We previously reported that activation of PPAR by its potent ligand WY14643 (WY) 
led to an induction of CYP1A1 expression in Caco-2 cells [6]. Also, when cells were 
coexposed to WY and 3-methylcholanthrene (3MC) (a potent PAH agonist of AhR), 
we observed a potentiation of CYP1A1 inducibility through AhR [7]. This effect was 
associated with an induction of AhR expression by PPAR, but the molecular 
mechanisms involved in this induction were not studied. 
PPAR and AhR might therefore work together to induce CYP1A1, but exert 
opposite effects towards inflammation. The effects of coexposure to PPAR and AhR 
ligands on the inflammatory state remain to be clarified. 
The aim of our work was to elucidate the molecular mechanism involved in AhR 
induction by PPAR in Caco-2 cells and to evaluate the effects of coexposure to 
ligands of these transcription factors on the expression of some inflammation genes. 
 
Materials and methods 
Chemicals. WY was from VWR International (Fontenay-sous-Bois, France); 
3MC, dimethylsulphoxide (DMSO) and bovine serum albumin (BSA) were from 
Sigma (Saint-Quentin-Fallavier, France). 
Cell culture. Caco-2 cells from human colorectal adenocarcinoma [8] were a 
generous gift from Dr. Le Bivic (IBDM, Marseille, France). Cells were maintained in 
Dulbecco’s modified Eagle’s medium (Eurobio, Les Ulis, France) supplemented with 
10% foetal bovine serum (FBS) (Eurobio), 2 mM L-glutamine (Life Technologies, 
Cergy-Pontoise, France), 1% non-essential amino acids (Life Technologies), 100 
UI/ml penicillin and 100 µg/ml streptomycin (Life Technologies), at 37 °C and 9% 
CO2. 
As serum contained PPAR agonists, 12 h before treatments the medium was 
removed and replaced with a serum-free medium containing 0.2% BSA. 
For the evaluation of AhR expression, cells were treated for 6 h with increasing 
concentrations of WY (10-400 µM). To evaluate the effect of coexposure to WY and 
3MC on mRNA level of CYP1A1 and some inflammation target proteins (IL1, 
ICAM1, MMP9), cells were pre-treated for 6 h with WY (200 µM) and treated for 6 h 
with a mixture of WY (200 µM) and 3MC (1 µM). 
For fluorescent imaging and luciferase assay, cells were treated as described above, 
for 24 h and 48 h respectively. 
RNA extraction and real time PCR. Total cellular RNA was isolated from 
Caco-2 cell cultures with Nucleospin RNAII (Macherey Nagel, France). Total RNA 
(1 µg) was reverse-transcribed using Moloney murine leukemia virus reverse-
transcriptase (Invitrogen, Cergy-Pontoise, France) and random primers at 42°C for 1 
h. 
Human AhR or CYP1A1 mRNA expression normalised to β2-microglobulin 
expression were determined using the LightCycler System (Roche Diagnostics, 
France) and the Faststart DNA master SYBRGreen I kit (Roche Diagnostics). The 
primers for AhR, CYP1A1 and β2-microglobulin were as follows:  
HumAhR-F: 5’-CAGAAAACAGTAAAGCCAATCC-3’ 
HumAhR-R: 5’-AATACAAAGCCATTCAGAGCC-3’ 
Humβ2m-F: 5’-CCGACATTGAAGTTGACTTAC-3’ 
Humβ2m-R: 5’-ATCTTCAAACCTCCATGATG-3’ 
PCR was performed with 4mM MgCl2, 0.25 µM of each primer and LightCycler 
FastStart DNA Master SYBR Green I mix in a total volume of 16 µl. Cycling 
conditions were as follows: 10 min denaturing at 95°C, followed by 45 cycles of 10 s 
denaturing at 95°C, 8 s primer annealing at 55°C and 8 s of fragment elongation at 
72°C. The melting curve was analysed with the LightCycler software and 
quantification was carried out with RelQuant software (Roche Diagnostics). 
Murine AhR and human ICAM-1, IL1, MMP9 mRNA expression normalised to 
β-actin expression were determined using the Mx3005P QPCR System (Stratagene, 
France) and the LightCycler 480 Probe Master (Roche Diagnostics). The reaction 
was performed as recommended by the supplier. The PCR efficiency was 90 ± 10%. 
The primers were designed using the assay design centre of the UPL website 
(www.universalprobelibrary.com). The primers sequences and the UPL probes used 
were as follows: 
MusAhR-F: 5’-TGCACAAGGAGTGGACGA-3’ 
MusAhR-R: 5’-AGGAAGCTGGTCTGGGGTA-3’ 
UPL Probe used for MusAhR: #27 
MusActin-F: 5’-AAGGCCAACCGTGAAAAGAT-3’ 
MusActin-R: 5’-GTGGTACGACCAGAGGCATAC-3’ 
UPL Probe used for MusActin: #56 
HumICAM1-F: 5’-CCTTCCTCACCGTGTACTGG-3’ 
HumICAM1-R: 5’-AGCGTAGGGTAAGGTTCTTGC-3’ 
UPL Probe used for HumICAM1: #71 
HumIL1-F: 5’-AACAGGCTGCTCTGGGATT-3’ 
HumIL1-R: 5’-TGGCTGCTTCAGACACTTGA-3’ 
UPL Probe used for HumIL1: #41 
HumMMP9-F: 5’-TGTACCGCTATGGTTACACTCG-3’ 
HumMMP9-R: 5’-GCCCCAGAGATTTCGACTC-3’ 
UPL Probe for HumMMP9: #53 
HumActin-F: 5’-CCCAGCACAATGAAGATCAA-3’ 
HumActin-R: 5’-CGATCCACACGGAGTACTTG-3’ 
UPL Probe for HumActin: #63 
AhR immunostaining. Caco-2 cells were plated on four-well/chamber Nunc® 
permanox slides and exposed for 24 h to 200 µM of WY. Immunostaining was 
performed as described elsewhere [9], using as primary antibody a rabbit polyclonal 
antibody raised against human AhR (sc-5579, Santa Cruz Biotechnology, Germany) 
(1/300), and as secondary antibody a goat anti-rabbit IgG-FITC (Santa Cruz 
Biotechnology) (1/200). Each image was obtained with a Leica DMIRBE microscope. 
AhR promoter luciferase assays. Fragments of 2.4 and 2.7 kb of the human 
AhR gene 5′-flanking region were subcloned into the pGL3-enhancer luciferase 
vector (Promega, France) using Kpn I and Xho I sites, as previously described [10]. 
The following primers were used: 
AhR-Prom(-2103/-2077): 5’-ACCATGTTCCACAGTGCCAATACAGGA-3’ 
AhR-Prom(-1764/-1738): 5’-TAGGATTTTTTTAAATCACTAAATTAA-3’ 
AhR-Prom(+637/+616): 5’-CAGCCGACGGCGGCGGCTACTC-3’ 
Restriction enzyme digestion and DNA sequencing were used to confirm the 
sequence of the promoter constructs. 
Cells in six-well plates were grown to 50% confluence before transfection. Transient 
transfections were performed by lipofection (lipofectin, Life Technologies) in 
a serum- and antibiotic-free medium containing 2% L-glutamine, with 0.5 µg of p3.1 
(containing the –1764/+637 region of AhR gene) or p3.48 (containing the –2103/+637 
region of the AhR gene). After 48 h treatment with 200 µM of WY, the luciferase 
activity was evaluated using the Luciferase Assay System from Promega (Promega).  
Site-directed mutagenesis of PPRE site of the AhR promoter. PPRE mutation 
of p3.1 and p3.48 was introduced using the QuickChange site-directed mutagenesis 
kit (Stratagene) to obtain the p3.1(PPRE) and the p3.48(PPRE). Sense and 
antisense primers were used for mutagenesis. The sense primers were as follows 
(the PPRE core is underlined and bold face indicates nucleotides mutated compared 
with the wild type sequence (Wt)): 
Wt: 5’-GCTCTTCTAAAATTAAAACAAAGATCATCGACCACAAAACACAATTG-3’ 
Mut-F : 5’-GCTCTTCTAAAATTAAAACAACAATCATCGACCACAAAACACAATTG-3’ 
Presence of the mutations was verified by DNA sequencing. Cells were transfected 
by the p3.1, or p3.48, or p3.1(PPRE), or p3.48(PPRE) and after a 48 h treatment 
with WY (200 µM), luciferase activity was evaluated as described above. 
Cloning of AhR PPRE sequence. Sense and antisense oligonucleotides 
containing a tandem of two AhR PPRE sites were synthesised with addition of Kpn I 
and Xho I opened restriction sites at the 5’ and 3’ ends respectively. After annealing, 
these two oligonucleotides were cloned in the corresponding sites of the pGL3 
Promoter vector containing a SV40 promoter. This construction was named pPPRE-
AhR-Luc. The forward oligonucleotide used was: 
5’-CTTCTAAAATTAAAACAAAGATCATCGACCACAACTTCTAAAATTAAAACAAAG
ATCATCGACCACAAC-3’, and the reverse oligonucleotide was: 
5’-TCGAGTTGTGGTCGATGATCTTTGTTTTAATTTTAGAAGTTGTGGTCGATGATC
TTTGTTTTAATTTTAGAAGGTAC-3’. The PPRE sites are underlined and Kpn I and 
Xho I digested restriction sites are bold face.  
Mice and treatments. Ten-week-old PPAR-deficient mice with a C57BL/6J 
genetic background [11] were bred at the INRA transgenic rodent facility (INRA, 
Toulouse, France). Age-matched male C57BL/6J mice were obtained from Charles 
River (Les Oncins, France) and were acclimatised to local animal facility conditions 
for 2 weeks. Mice were treated per os for a week with 30 mg/kg WY or vehicle (three 
animals per group). In vivo studies were conducted under European Union guidelines 
for the use and care of laboratory animals and were approved by the institutional 
ethics committee. 
Statistical analysis. All experiments were repeated at least three times. Means 
± S.D. were calculated for each group. Statistical significance was determined using 
Tukey’s multiple comparison test, except for AhR PPRE luciferase assays where the 
Mann-Whitney test was performed. 
 
Results 
Effects of WY exposure on AhR expression in Caco-2 cells. As shown in 
Figure 1A, treatment of Caco-2 cells with increasing amounts of WY led to an 
induction of AhR expression, with a maximum effect with 100 µM WY (3.5-fold, 
p < 0.01). The transcript induction was associated with an increase in protein 
expression (Fig. 2) in the cytoplasm and nucleus. 
Effects of WY treatment on colic expression of AhR in wild type and PPAR 
knockout mice. To verify in vivo that WY exposure leads to an induction of AhR 
expression, wild type mice and PPAR knockout mice were treated with 30 mg/kg of 
WY. As shown in Figure 1B, WY enhanced AhR mRNA expression in the colon of 
wild type mice (about 2-fold, p < 0.01), but not in PPAR knockout mice. 
Effects of WY exposure on AhR promoter activity in Caco-2 cells. To check the 
transcriptional origin of AhR induction by WY, Caco-2 cells were transiently 
transfected with p3.1 or p3.48. As shown in Figure 3A, WY efficiently induced the 
transactivation of the AhR wild type promoter (2.5-fold with p3.1, p < 0.01; 1.6-fold 
with p3.48, p < 0.01). The greatest induction observed with p3.1, containing the 
-1764/+637 region of AhR gene, is consistent with the literature, the region between 
-2142 and -1764 of human AhR being reported to contain negative regulatory 
elements [10]. The mutation of the putative PPRE site located between -1282 and -
1270 of human AhR promoter abrogated luciferase induction, demonstrating that this 
PPRE is functional and involved in AhR induction mediated by WY. Also, when 
luciferase expression was directly driven by human AhR PPRE, WY treatment 
caused an increase in luciferase [Fig. 3B]. 
Effects in Caco-2 cells of co-exposure to WY and 3MC on the expression of 
genes coding for some inflammation proteins. Figure 4 showed the effect of 3MC, 
WY, and 3MC+WY on some inflammation target proteins. ICAM1 mRNA level was 
not modified by 3MC and 3MC+WY, WY alone reduced its expression by about 50% 
(p < 0.01). IL1 mRNA was increased by 3MC (2.5-fold, p < 0.01), was slightly 
reduced by WY (-30%), and was not modified by 3MC+WY. MMP9 transcript was 
induced by 3MC (3.9-fold, p < 0.01) and slightly enhanced by WY and 3MC+WY 
(about 1.5-fold). 
 
Discussion 
Substances in the environment, including the diet, exert their biological effects by 
modulating the activity of transcription factors. We previously reported that PPAR 
activation potentiated CYP1A1 induction mediated by the AhR pathway [7], but the 
molecular events involved in this effect were not known. 
Here we find that this potentiation is probably partly due to a transcriptional activation 
of AhR expression by PPAR ligand (WY). This agrees with the results we obtained 
with PPAR KO mice, in which we did not observe any colic induction of AhR after 
WY treatment. 
Analysis of human AhR promoter (Mathinspector [12]) revealed one putative PPRE 
site located at positions -1282/-1270. This PPRE seems to play an important role in 
AhR expression as its mutation led to the suppression of AhR promoter activation by 
WY, and as a construction containing only the PPRE-AhR sequences can be 
activated by WY. 
AhR has been largely studied owing to its central role in the bioactivation of many 
environmental procarcinogens such as PAHs and arylamines. The AhR pathway is 
thus commonly viewed as an adaptive response toward xenobiotic agents. Recent 
data argues that AhR is also involved in normal physiology and development [13]. 
AhR activation leads to inflammation though the induction of IL-1 like pro-
inflammatory cytokines [4, 14, 15, 16, 17], probably via NFB [3] or AP-1 [18]. On the 
other hand, the anti-inflammatory activity of PPAR through the repression of NFB 
and AP-1 is well known [5]. Since AhR and PPAR exert opposite effects towards 
inflammation, we examined the effects of coexposure to 3MC and WY on some 
inflammation target proteins. 
We showed that 3MC treatment induces the expression (mRNA) of the potent 
pro-inflammatory cytokines IL-1 (Fig. 4). Similar results obtained after PAH or dioxin 
exposures are described in other cell types, such as macrophages [17], fibroblast-like 
synoviocytes [15], and keratinocytes [16]. This induction was described as being 
mediated by AhR [16]. Another well-known pro-inflammatory cytokine, TNF, is also 
reported to be upregulated by PAH and dioxins, through the ERK pathway and not 
the AhR one [19]. In our conditions, we failed to detect any TNF mRNA in Caco-2 
cells, either before or after 3MC exposure (data not shown). WY did not significantly 
modify IL-1 mRNA levels compared with control cells, but abrogated the inductive 
effect of 3MC (Fig. 4). Although the upregulation of AhR expression induced by WY 
may lead, as observed with CYP1A1, to a potentiation of IL-1 induction by 3MC, our 
data demonstrate that the anti-inflammatory effect of PPAR overrides the pro-
inflammatory effect of AhR. 
The upregulation of IL-1 is associated with the induction of various targets, including 
cytokines, cellular adhesion proteins and metalloproteinases (MMP). MMPs degrade 
extracellular matrix (ECM) components and activate growth factor, thereby 
contributing to physiological events (tissue remodelling in pregnancy, wound healing, 
angiogenesis) and pathological conditions (cancer, arthritis, periodontis) [20]. Among 
the different MMPs expressed in the intestine, we studied MMP9 because it is largely 
involved in intestinal inflammation [21] and upregulated by AhR activation [22]. 
Results obtained for MMP9 are comparable to those obtained for IL-1 (Fig. 4). 3MC 
dramatically induces MMP9 mRNA. WY alone does not significantly modify it, but 
suppresses the inductive effect of 3MC. MMPs were initially characterised as 
proteases that could degrade the ECM, but they are now known to increase cancer-
cell growth, migration, invasion, metastasis and angiogenesis [23]. Chemical 
carcinogenesis induced by AhR ligands has been mainly associated with the 
induction of CYP1 family [1]. Taken together, these data suggest that AhR-mediated 
chemical carcinogenesis, apart from CYP1, may also involve MMP upregulation. 
ICAM-1 is another major inflammatory protein that functions in cell-cell and 
cell-matrix adhesive interactions. These interactions are critical for the 
transendothelial migration of leucocytes and the activation of T cells, and ICAM-1 is 
associated with a variety of inflammatory diseases [24]. As shown in Figure 4, 3MC 
does not modify ICAM-1 mRNA level. An increase in ICAM-1 expression was 
described in dendritic cells from TCDD-treated mice, requiring the presence of AhR 
[25]. The lack of ICAM-1 induction in intestine epithelial Caco-2 cells after 3MC 
exposure was probably due to specific cell/tissue regulation, and further data are 
required to confirm this hypothesis. As previously described in vivo in mice [26], WY 
was able to repress ICAM-1 expression. 
Our diet contains nutrients and cooking by-products that can modulate intestinal 
physiology, notably through the activation and repression of transcription factors. It 
has been demonstrated that oxidised omega-3 fatty acids can inhibit NFB activation, 
via a PPAR-dependent pathway [27]. Consumption of marine fish oil has been 
reported to improve the prognosis of inflammatory disorders, including inflammatory 
bowel disease (IBD) [28]. The effect of the activation of AhR, notably by PAH, on the 
inflammatory state of the intestine was not well known. Our data obtained in vitro, 
suggest that PAH can induce an inflammation in vivo through the increase in 
proinflammatory cytokines, such as IL-1. This hypothesis is strengthened by 
epidemiological data suggesting that active cigarette smoking, which leads to PAH 
exposure, is associated with the development of Crohn's disease, and passive 
smoking exposure and maternal smoking at birth are associated with an increased 
risk of children developing IBD [29-30]. Hence exposure to environmental AhR 
agonists, such as PAH, through tobacco smoke or diet, may worsen the risk of 
developing IBD, while omega-3 fatty acid food supplementation may reduce it. These 
hypotheses need to be evaluated by in vivo experimental studies. 
In conclusion we demonstrate in Caco-2 cells that PPAR activation by WY 
transcriptionally induces AhR expression through a PPRE site located within its 
promoter. This effect leads to a potentiation of CYP1A1 induction by 3MC, a potent 
AhR agonist. In addition to the modulation of xenobiotic metabolism, 3MC also 
increases IL-1 and MMP9, which are major inflammatory targets. WY co-treatment 
abrogates the 3MC proinflammatory effect. Thus the anti-inflammatory effect of 
PPAR overrides the pro-inflammatory effect of AhR. Further experiments are 
required to elucidate the molecular events involved in these inflammatory events, and 
to evaluate in vivo the pro-inflammatory effect of AhR agonists such as PAH and their 
role in the development of IBD. 
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Figure legends 
 
Fig. 1. WY induces AhR expression. A: Effect of increasing amounts of WY (0-400 
µM) on AhR mRNA level in Caco-2 cells. *: p < 0.01, **: p < 0.05. B: Effect of WY (30 
mg/kg) treatment on colic AhR mRNA level in wild type and PPAR knockout mice. 
Cwt: control wild type mice. WYwt: wild type mice treated with WY. Cko: control 
PPAR knockout mice. WYko: PPAR knockout mice treated with WY. *: p < 0.01. 
 
Fig. 2. Effect of WY (200 µM) on AhR protein expression, in Caco-2 cells. A: 
untreated cells stained with DAPI. B: AhR immunostaining in untreated cells. C: cells 
treated with WY and stained with DAPI. D: AhR immunostaining in cells treated with 
WY. 
 
Fig. 3. Effect of WY (200 µM) on AhR transcriptional activity. A: Effect of WY on AhR 
promoter activity in Caco-2 cells transfected with constructions harbouring the wild 
type sequence, or a sequence in which the PPRE site was mutated. B: Effect of WY 
on luciferase activity in Caco-2 cells transfected by a construction where the 
luciferase expression is under the control of the AhR PPRE. *: p < 0.01, **: p < 0.05. 
 
Fig. 4. Effect of 3MC (1 µM), WY (200 µM), and 3MC+WY (1 and 200 µM 
respectively) on the mRNA of some inflammation target proteins, in Caco-2 cells. C: 
control cells. 3MC: cells treated with 3MC. WY: cells treated with WY. 3MC+WY: 
cells treated with 3MC and WY. *: p < 0.01. 
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Fig. 4 
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